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DiabetesAgeing and diabetes share a common deleterious phenomenon, the formation of AdvancedGlycation Endproducts
(AGEs), which accumulate predominantly in collagen due to its low turnover. Though the general picture of
glycation has been identiﬁed, the detailed knowledge of which collagen amino acids are involved in AGEs is still
missing. In this work we use an atomistic model of a collagen ﬁbril to pinpoint, for the ﬁrst time, the precise loca-
tion of amino acids involved in the most relevant AGE, glucosepane. The results show that there are 14 speciﬁc
lysine–arginine pairs that, due to their relative position and conﬁguration, are likely to form glucosepane. We
ﬁnd that several residues involved in AGE crosslinks are within key collagen domains, such as binding sites for
integrins, proteoglycans and collagenase, hence providing molecular-level explanations of previous experimental
results showing decreased collagen afﬁnity for key molecules. Altogether, these ﬁndings reveal the molecular
mechanism by which glycation affects the biological properties of collagen tissues, which in turn contribute to
age- and diabetes-related pathological states.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
There is a wealth of clinical data available in the literature on age-
related alterations in the functioning of all human tissue, including sus-
ceptibility to injury and to reduce healing capacity (Semba et al., 2010).
Noticeably, these deleterious effects of ageing all involve, to a greater or
lesser degree, the most important structural protein, namely, collagen.
Collagen molecules make up 30% of total protein in the body and form
the basis of many vital organs such as the heart, bone, kidney and skin
(Kadler et al., 2007). The collagen molecule is synthesized as a trimeric
molecule containing two α1, and one α2 chains, each of about 1000
amino acids. Upon secretion from the cell, collagen molecules assemble
into ﬁbrils and are enzymatically crosslinked (Sweeney et al., 2008).
In aging, type I collagen becomes less ﬂexible and more acid insolu-
ble, which correlates with the accumulation of nonenzymatic crosslinks
known as Advanced Glycation End-products (AGEs) (Brennan, 1989;
Bailey, 2001). Glycation and AGEs form in vivo on collagen via
nonenzymatic reactions that covalently add a sugarmoiety onto the pro-
tein (Paul and Bailey, 1996) and their accumulation is particularly high in
long-lived proteins, such as collagen. Indeed, collagen half-life varies be-
tween tissues but remains generally large, from1 to 2 years for bone col-
lagen to about 10 years for type I in skin (Avery and Bailey, 2006). The
low biological turnover of collagen makes it therefore susceptible toment of Electronics, Information
: +39 022399 4142.
).
ights reserved.interaction withmetabolites, primarily glucose. Besides the elderly, peo-
plewho sufferwith type II diabetes are particularly badly affected byAGE
cross-linking (Andreassen et al., 1981; Schnider and Kohn, 1982).Whilst
elder people have abundance of long-lived proteins that have slowly ac-
cumulated AGE crosslinks, type II diabetics have abnormally high levels
of glucose in their system leaving a surplus which is available to glycate
proteins.
Several glycation crosslinks have been proposed (Avery and Bailey,
2006) but are all present in minute quantities except glucosepane
(Sell et al., 2005), which is a lysine–arginine crosslinking AGE which
could make a signiﬁcant change to the biomechanics and biological ac-
tivity of ﬁbrillar collagen (Fig. 1a). Nonetheless, despite the recognized
importance of AGEs, there are still several important open questions
about their role in the onset of pathological conditions. In particular,
there are two different aspects of collagen glycation that need to be
further understood. One is the biomechanical effects of nonenzymatic
intermolecular crosslinking: glucose reaction with the amino acid
side-chains, and subsequent further reaction to form a crosslink with
an adjacent collagen molecule, result in a modiﬁcation of the physical
properties of the collagen (e.g.: elasticity), but the detailed effects of
AGEs on collagen nanomechanics are still unknown. The second aspect
is related to collagen interactions: glycation of speciﬁc amino acid in-
volved in intermolecular recognition could lead to the dramatic modiﬁ-
cation of the interaction of collagen with other molecules such as
proteoglycans (PG), enzymes (e.g., collagenase) and cell integrins. How-
ever, it is still not clear which collagen amino acids — and thus which
collagen binding sites — are mostly affected by AGEs.
Fig. 1. Collagen ﬁbril and glucosepane. Panel (a) shows a schematic of collagen ﬁbril and the formation of glucosepane, which covalently links Lysine and Arginine sidechains. The two
amino acids can belong to separate molecules (top), forming an intermolecular crosslink, or to the same molecule (bottom). Panel (b) shows the chemical structure of glucosepane,
which crosslinks lysine (blue) to arginine (red). Panel (c) shows the molecular model of glucosepane, used to evaluate the distances between the terminal atoms of the two residues
(d1 ≈ 2.6 Å, d2 ≈ 3.8 Å).
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the collagenmicroﬁbril (Gautieri et al., 2011) to pinpoint which speciﬁc
amino acids are involved in the formation of the most important AGE
crosslinks (i.e., glucosepane) within the collagen ﬁbril. The molecular
details of this model allow to infer about the positions of likely lysine–
arginine crosslinking sites and, when coupled with the mapping of
collagen binding sites (Sweeney et al., 2008), it allows to relate the
glycation sites with biological malfunctions.2. Results
We use the atomistic model of collagen type I microﬁbril, based on
X-ray crystallography (Orgel et al., 2006) and described in detail in pre-
viousworks (Gautieri et al., 2011; Nair et al., 2013), to identify themost
likely position of AGE crosslinks. Our investigation is limited to a single
speciﬁc AGE, namely glucosepane, because its levels are found to be up
to 1000 times higher than any other nonenzymatic crosslink (Monnier
et al., 2005; Sell et al., 2005). The molecular model of glucosepane (a
lysine–arginine crosslink) shows that in the compound the distance be-
tween the terminal atoms of the two amino acids involved is between
2.6 Å and 3.8 Å (see Fig. 1b–c). The larger distance (increased by 30%)
is used as a cutoff to identify, within the atomistic three-dimensional
collagen microﬁbril model, lysine–arginine pairs that are close enough
to form glucosepane crosslinks. Results show that there are 14 lysine–
arginine pairs that spend at least 25% of the time closer than the cutoff
distance (see Table 1), and thus are located in a relative position such
that, in the presence of glucose, they are able to form a glucosepane
crosslink. Within the most frequently observed pairs there are 6 lysine
residues from α2 chain (8 from α1 chain) and 5 arginine residues
from α2 chain (9 from α1 chain). Out of 14 crosslinks, six are intramo-
lecular, whereas 8 involve lysine and arginine residues from different
collagen molecules. The full list of lysine–arginine pairs (86) that are
found closer than the cutoff distance in at least one frame of the molec-
ular dynamics trajectory is given in Table S1.2.1. Lysine residues
Two lysine residues most often found close to an arginine residue
(LYS α1-434 and LYS α2-453) are also known to be two of the four
preferentially glycated residues (Reiser et al., 1992). The other two pre-
ferred glycation sites, i.e. LYSα2-479 and LYSα2-924, are found close to
argininewith amuch lower frequency (see full list in Table S1) and thus
are less likely to form glucosepane crosslink (even if glycated). Interest-
ingly, two lysine–arginine pairs that most likely form nonenzymatic
crosslinks involve LYS α1-87, which is known to form enzyme-
mediated crosslinks (Eyre et al., 2008). Since physiological enzyme-
mediated crosslinks are formed at young age and then their number
remains constant (Monnier et al., 2005) whereas nonenzymatic
crosslinks appear at older age, the LYS α1-87 residues already involved
in physiological crosslinks aremost likely not involved in AGE crosslinks.
However, the LYSα1-87 (there are two for each collagenmolecule) that
are not involved in physiological crosslinks could be glycated and
involved in nonenzymatic crosslinks. Concerning the collagen binding
sites, many of the lysines involved in glucosepane formation are within
or close to integrin, heparin or proteoglycan (keratan sulphate) binding
sites. Notably, lysine α1-531 is within the cell interaction domain,
which features sequence GFPGER502–507, which is considered to be criti-
cal for collagen–cell interaction (Sweeney et al., 2008).2.2. Arginine residues
Several arginines involved in AGE crosslinks are foundwithin or close
to integrin, heparin or proteoglycan (keratan sulphate or dermatan sul-
phate) binding sites (see Table 1). In particular, ARG α1-501 is located
right next to the GFPGER502–507 sequence, which is a key collagen–cell
interaction domain. Another crucial residues involved in glucosepane
formation is ARG α1-789, which is close to the binding site of matrix
metalloproteinase-1 (MMP-1), the most important collagenase enzyme
(Sweeney et al., 2008).
Table 1
Glucosepane-forming lysine–arginine pairs. Eachamino acid is identiﬁedby thehelical number and chain (notationα1-a andα1-b are used to distinguish the twoα1 chains). For eachpair
it is reported the time in which the terminal atoms of the side chains are closer than the cutoff of 5 Å, thus in a conﬁguration promoting the formation of glucosepane crosslink. Involve-
ment of major intermolecular interactions or binding sites (BS) is reported in the notes (Sweeney et al., 2008). Intermolecular AGEs (notedwith *) are likely to affect themechanics of the
tissue, providing load transfer between molecules in addition to enzymatic crosslinks.
Residue Chain Residue Chain Time closer
than cutoff (%)
Intermolecular
crosslinks
Notes
LYS 434 α1-a ARG 906 α2 96.84% * LYS: preferred glycation site, close to α1β2 integrin BS.
LYS 564 α1-b ARG 567 α1-a 93.97% LYS: close to keratan sulphate BS. ARG: within keratan sulphate BS.
LYS 87 α1-a ARG 789 α1-a 87.64% * LYS: involved in enzymatic x-link, within heparin BS. ARG: close to
MMP-1 cleavage site.
LYS 531 α1-a ARG 291 α2 83.62% * LYS: within the cell interaction domain, α1β1/α2β1 integrin BS.
LYS 453 α2 ARG 453 α1-b 73.28% LYS: preferred glycation site. ARG: within keratan sulphate BS.
LYS 420 α2 ARG 888 α1-b 69.25% * ARG: within dermatan sulphate BS.
LYS 264 α2 ARG 501 α1-b 69.25% * LYS: within α2β1 integrin BS. ARG: within cell interaction domain,
close to α1β1/α2β1/α11β1 integrin BS.
LYS 87 α1-a ARG 90 α1-a 50.57% LYS: involved in enzymatic x-link, within heparin BS. ARG: within
α1β1 integrin BS, within heparin BS.
LYS 657 α1-a ARG 420 α1-b 45.69% *
LYS 564 α2 ARG 90 α1-b 32.18% * LYS: close to keratan sulphate BS. ARG: within a1b1 integrin BS,
within heparin BS.
LYS 252 α1-a ARG 252 α2 28.74%
LYS 290 α2 ARG 291 α1-a 27.87%
LYS 108 α1-b ARG 342 α2 25.57% * LYS: within α1β1 integrin BS.
LYS 974 α2 ARG 977 α2 25.57%
91A. Gautieri et al. / Matrix Biology 34 (2014) 89–953. Discussion
Previous works have shown that the major nonenzymatic crosslink
in collagen is glucosepane (Monnier et al., 2005; Sell et al., 2005), an
AGE crosslink involving lysine and arginine residues. It has been
shown that the presence of AGEs affects the biological properties of col-
lagen, and in particular its interaction with a series of extracellular ma-
trix molecules (Andreassen et al., 1981; Monnier and Cerami, 1981;
Kent et al., 1985; Reigle et al., 2008), suggesting that glycation affects
certain speciﬁc collagen binding sites. However, the identiﬁcation of
which exact amino acids, along the triple helix, are involved in the for-
mation of AGEs have remained elusive. The novelty of our work is that
we pinpoint, for the ﬁrst time, the exact position of 14 lysine–arginine
pairs that are located, within the collagen ﬁbril, close enough to form
nonenzymatic crosslinks associated with the ageing process and diabe-
tes (see Table 1).
Among these proposed crosslinks, 8 are intermolecular crosslinks,
whereas 6 involve amino acids from the same molecule. In addition to
these 14 crosslinks, there are several other lysine–arginine pairs (72)
that are close enough only for a minor part of the time and thus less
likely — but still able — to form AGE crosslinks (see full list in Table S1).
During its biosynthesis, collagen is subject to several post-
translational modiﬁcations, where the most important are proline
hydroxylation, lysine hydroxylation and hydroxylysine glycosylation.
The last two modiﬁcations could potentially affect AGE formation, since
they involve lysine, but their effect is likely negligible. Lysine hydroxyl-
ation leaves intact the amine group which is required for glucosepane
formation and thus hydoxylysines can participate in AGE formation
(Saito and Marumo, 2010). In the case of glycosylated hydroxylysine
the amine group is preserved but the bulky sugar chains could prevent
the AGE formation by steric hindrance. However, glycosylation in type
I collagen — the main focus of our work and the most common type —
is rather low (≈1%) (Kivirikko and Myllyla, 1979; Shinkai and
Yonemasu, 1979), thus not affecting the overall AGE formation.
The effects of AGEs are twofold: 1) mechanical: intermolecular
crosslinking may result in major alterations of the physical properties
(e.g., increased ﬁbril stiffness), which are observed to change slowly
with age and at higher rate in diabetes mellitus due to high glucose
levels; 2) intermolecular interactions: AGEs alter the biochemical pro-
ﬁle of the collagen molecule and if they occur at speciﬁc sites can affect
the intermolecular and cell–collagen interactions.3.1. Mechanical effects
Themechanical effects of AGEs on collagenous tissues are long known
and include stiffening, increased failure load and decreased viscoelasticity
of tendons (Galeski et al., 1977; Andreassen et al., 1981; Danielsen and
Andreassen, 1988; Li et al., 2013), loss of bone plasticity and toughness
(Tang and Vashishth, 2011; Zimmermann et al., 2011), stiffening and in-
creased fragility of cartilage (Verzijl et al., 2002). We ﬁnd that there are 8
lysine residues for each collagen molecule that are often very close to an
arginine residue of an adjacent molecule and thus, in the presence of
glucose, they are likely to form an intermolecular crosslink. Simpliﬁed
mechanical models of tendon ﬁbrils (Buehler, 2008) and bone (mineral-
ized) ﬁbrils (Siegmund et al., 2008) have previously investigated in a
parametric way the possible effects of increased crosslinking. These
works have shown that already a single nonenzymatic crosslink (in addi-
tion to the physiological enzymatic ones) is able to drastically change
themechanical properties of collagen tissues, inducing increased stiffness
and decreased toughness. In this work we show that the number of
intermolecular crosslinks is likely ≈10 per molecule and thus undoubt-
edly responsible for the observe stiffening of collagen tissues.
3.2. Effects on molecular recognition
In Fig. 2 we have represented the amino acids involved in
nonenzymatic crosslinks on the map of the major collagen domains, to
help ﬁnd the possible inﬂuence of AGE on collagen interaction with
other molecules. Glycated collagen has been found to show reduced
afﬁnity for heparin and keratan sulphate proteoglycan, but not for
dermatan sulphate and decorin proteoglycans, alongsidewith impaired
endothelial cell migration (Reigle et al., 2008). Our results provide
strong evidences that glucosepane crosslinks are close or directly in-
volve the two proposed binding sites for keratan sulphate (residues
451–461 and 565–575) and for heparin (residues 87–90), but do not
involve the decorin core binding site nor the ﬁve proposed dermatan
sulphate binding sites (except for arginine α1-888) (see Fig. 2). More-
over, several amino acids proposed to form AGE crosslinks lie within
the cell-interaction domain. In particular, ARG α1-501 is located right
next to the binding sites of α1β1/α2β1 integrins (GFPGER502–507),
which are the predominant type I collagen receptors on endothelial
cells (Di Lullo et al., 2002). We also found that arginine α1-789 is very
close to the cleavage site of MMP-1, the most important enzyme
Fig. 2.Human collagen type Iﬁbril domains andmajor binding sites. The collagen triple helix sequence is shown (source Pubmed,α1(I) accession#NP000079.2 andα2(I) NP000080.2) and theproposed location of glucosepane-forming amino acids is
highlighted in green. Most of these amino acids fall close or within major binding sites for proteoglycans, integrins and enzymes (yellow) or within secondary binding sites for integrins (blue). Collagen domains are obtained from (Sweeney et al.,
2008). Green: residues involved in glucosepane crosslink. Pink background: major cell interaction domain. Yellow: major binding sites for proteoglycans, collagenases, heparin and integrin (GFPGER). Cyan: secondary integrin binding sites. * Enzy-
matic cross-links. ○ Preferred glycation sites. ——MMP-1 Cleavage site. HEP: Heparin. KSPG: Keratan sulphate proteoglycan. DSPG: Dermatan sulphate proteoglycan.
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93A. Gautieri et al. / Matrix Biology 34 (2014) 89–95responsible for the degradation and remodeling of extracellular matrix.
This modiﬁcation close to the enzyme binding site due to glycation and
crosslinking could explain the observed resistance to collagenases of
glycated collagen (Andreassen et al., 1981; Monnier and Cerami, 1981;
Kent et al., 1985).
3.3. Other AGEs
Glucosepane has been found to be largely more common than other
AGEs, with levels 10–1000 times higher than other AGEs (Sell et al.,
2005). The second most important AGE crosslink, named MOLD, is a
Lysine–Lysine crosslink (Monnier et al., 2005). Hence it is interesting
to investigate if this is due to a geometric probability. For this we inves-
tigate the average number of Lys–Arg pairs in close proximity (which
could lead to glucosepane formation) and the number of Lys–Lys pairs
(which could lead toMOLD). As it can be anticipated form the sequence
of the three chains, our analysis of Lys–Lys pairs shows that there are
hundreds of Lys–Lys pairs for which the time spent closer than cutoff
is higher than 80%. All these pairs are formed by same-position Lysines,
arising from the fact that the two α1 chains are identical and the α2
chain has a high homology. Apart from same-position Lysines, there
are a few pairs with high (N25%) geometric propensity for AGE forma-
tion, reported in Table 2. These results suggest that Lys–Lys AGEs are
favored from the geometric point of view, particularly thanks to the
proximity of same-position Lysines. This in turn suggests that the chem-
ical pathwaymust be muchmore favorable for glucosepane, in order to
explain its experimentally observed predominance. Furthermore, it is
important to observe that all AGE cross links are either Lys–Arg or
Lys–Lys (Monnier et al., 2005),hence the differences in the levels of
different AGEs cannot be due to the proximity of involved amino acids
but must be dictated by the availability of cross-linking agent (e.g., glu-
cose, fructose, methylglyoxal, …) and on the speciﬁc differences in
formation kinetics.
4. Conclusions
Although the age- and diabetes-related changes in collagen physical
properties have been known for several decades, the molecular mecha-
nisms are only now being unraveled. In this work, for the ﬁrst time, we
identify the speciﬁc amino-acids involved in nonenzymatic crosslinking
of collagen, and discuss the mechanical and biological consequences,
which include stiffening of the tissue and impaired interaction with
proteoglycans, collagenases and cell's integrins.
Our approach is meant to be complementary to biochemical as-
says and aims to identify glycation points with single-residue preci-
sion. This possibility has been unlocked by the recent development
of the atomistic model of collagen ﬁbril (Gautieri et al., 2011). The
identiﬁcation of glycation sites is based on a geometric basis: indeed,
LYS and ARG residues to form a covalent bond must be close enough
for the glucose-mediated cross-link to be formed. The major limita-
tion of the work is related to the fact that vicinity in space represents
a necessary but not sufﬁcient condition for cross-link to occur. In this
view, the list of LYS/ARG pairs must be read as a likelihood of AGE
crosslinks formation. A further limitation is that our model doesTable 2
List of AGE-forming lysine–lysine pairs, excluding same-position lysines.
Residue Chain Residue Chain Time closer than cutoff (%)
LYS 408 α2 LYS 174 α2 67.7%
LYS 936 α1-a LYS 933 α2 61.3%
LYS 290 α1-b LYS 59 α2 31.9%
LYS 884 α2 LYS 648 α2 30.6%
LYS 974 α1-b LYS 270 α2 25.0%not take in consideration post-translational modiﬁcation and stable
interaction with extracellular matrix biomolecules that could pro-
tect binding sites from glycation.
Glycation is believed to provide changes in mechanical properties, it
would be extremely interesting to investigate the changes inmechanics
in light of the discoveries put forth in this work. The fully atomistic
modeling of AGEs mechanical effects is impractical for several reasons:
the atomistic model used in this work is based on the microﬁbril unit
cell and employs periodic boundary conditions to model the entire
ﬁbril, which hinders the possibility to add mechanical crosslinks that
involve the periodic images. On the other hand, considering a non-
periodic atomistic model of a collagen ﬁbril would result in a model
size with prohibitive computational costs. A feasible strategy could be
the use of simpliﬁed models similar to those developed in previous
works (Buehler, 2008; Siegmund et al., 2008) that would greatly reduce
the particles of the system. In this case, the modeling of ﬁnite size ﬁbrils
would result in high but treatable computational costs. However, this
strategy involves the careful parameterization of the coarse-grain
model and in particular of the AGE crosslinks. This would allow investi-
gating in a parametric way the inﬂuence of the amount AGEs crosslinks,
which is largely uncertain: it has been proposed (Sell et al., 2005) that
there is one AGE every 2 molecules in diabetic collagen and one AGE
every 5 molecules in aged collagen. However, these data do not distin-
guish between intra-molecular crosslinks (which are anticipated to
not contribute tomechanical properties) and inter-molecular crosslinks
(which would stiffen the ﬁbril). Furthermore, it is still unknown how
AGEs are distributed through the ﬁbril cross-section (i.e., if they are
homogeneously distributed or only on the surface) and it could be
very interesting to test the different hypotheses.
Life-expectancy has increased substantially in recent years and this
is a general trend in western countries. This, coupled to a decrease in
birth rate, means that society now is becoming year by year older. The
every-day effects of aging are clear for all to see: the increased incidence
of arthritis and diabetes, the reduced heart and kidney function, the re-
duced mobility etc. Most of these put a strain on global health services,
as well as decreasing of independence and the burden of medical care.
But what if we could moderate the aging process? The most promising
approach likely involves the use of deglycating enzymes, however avail-
able enzymes are either ATP-dependent (thus not working in the extra-
cellular environment) or are only able to deglycate small substrates
(and thus not suitable for large proteins such as collagen) (Sell and
Monnier, 2012). Hence, the de novo engineering of deglycation enzymes
is mandatory for the successful reversion of AGEs and, to this aim,
knowing the precise substrate (i.e., the local collagen sequence) where
the engineered enzyme should act represents a necessary preliminary
step. In this view our work could pave the way for the development of
advanced strategies for themitigation of ageing and diabetes molecular
effects.
5. Computational procedures
The goal is to exploit full-atomistic modeling of collagen that
enables us to perform a systematic study of collagen glycation from
a fundamental, molecular point of view. This allows us to answer
questions such as “what are the amino acids involved in AGE
crosslinks?” and to provide molecular-level explanations for the
experimentally-observed modiﬁcation of collagen biological and
mechanical properties.
5.1. Collagen atomistic model
The geometry and composition of the molecular model are fully
described in previous works (Gautieri et al., 2011; Nair et al., 2013).
Brieﬂy, the collagen microﬁbril model used here is based on Protein
Data Bank entry 3HR2 (Orgel et al., 2006). Since the structure reported
in (Orgel et al., 2006) includes only backbone alpha carbons and the
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obtain a full-atom structure with the human collagen type I sequence.
The ﬁbril model is solvated using the solvate plugin of VMD
(Humphrey et al., 1996) by adding TIP3P water molecules. Since the
molecule at physiological pH includes a net charge (positive net charge
+34), counterions (Cl−) are added in order to keep the system neutral.
The ﬁnal solvated all-atom system contains ≈ 75,000 atoms, includ-
ing ≈ 36,000 water atoms. The ﬁrst step of energy minimization is
performed by a steepest descent algorithm using the NAMD 2.9 code
and the CHARMM force ﬁeld (MacKerell et al., 1998), which includes
parameters for hydroxyproline amino acid (HYP) found in collagen
(Park et al., 2005). This forceﬁeld has beenwidely validated for a variety
of biochemical models of proteins including collagen (Gautieri et al.,
2009, 2012a, 2012b; Qin et al., 2012).5.2. Fibril equilibration
Extensive full atomistic simulations are carried out using the NAMD
2.9 code. Rigid bonds are used to constrain covalent bond lengths
involving hydrogen atoms, thus allowing an integration time step of
2 fs. Nonbonding interactions are computed using a cut-off for neighbor
list at 1.35 nm, with a switching function between 1.0 and 1.2 nm for
van der Waals interactions, while the Particle-Mesh Ewald sums
(PME)method is applied to describe electrostatic interactions. The ﬁbril
model is equilibrated through 100 ns molecular dynamics simulations
at a temperature of 310 K (37 °C). The structural convergence of the
structure is reached within the ﬁrst 30 ns, hence the remaining 70 ns
are used for analysis.5.3. Identiﬁcation of nonenzymatic crosslinks
Nonenzymatic crosslinks derived from AGEs are identiﬁed on a geo-
metric basis. The principal crosslinking AGE is glucosepane (Sell et al.,
2005), which is lysine–arginine crosslinks derived from glucose. The
molecular model of glucosepane is built and simulated for 100 ps
using LAMMPS code (Plimpton, 1995) and the ReaxFF force ﬁeld
(Duin et al., 2001). The trajectory of the simulation is used to deﬁne
the average distances between the lysine Nζ atom and the two arginine
Nη atoms, involved in the formation of the crosslink (see Fig. 1b–c). The
average distances are found to be 2.6 Å (between lysineNζ and arginine
Nη1 atom) and 3.8 Å (between lysine Nζ and arginine Nη2 atom).
Glucosepane crosslink can form in the presence of glucose only for
lysine–arginine pairs that are close enough for the reaction to occur.
Hence, the 100 nsmolecular dynamics trajectory of the collagenmicro-
ﬁbril is analyzed through an in-house VMD script in order toﬁnd lysine–
arginine pairs for which the distance between lysine Nζ and any one
arginine Nη is below a 5 Å cutoff, chosen as 130% the larger of the two
calculated distances within glucosepane) and the basis of previous
studies suggesting that a proximity of ≈ 5 Å is a good predictor of
AGE formation (Acosta et al., 2000).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.matbio.2013.09.004.Acknowledgments
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